home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Scorpion Therapeutics to Present STX-478 Initial Phase 1/2 Data at ESMO Congress 2024
Scorpion Therapeutics to Present STX-478 Initial Phase 1/2 Data at ESMO Congress 2024
Post navigation
Previous Post
Previous
MOMA Therapeutics Announces Initiation of Phase 1 Clinical Trial for MOMA-313, a Novel Polymerase Theta Helicase Inhibitor
Next Post
Next
Tango Therapeutics to Participate in Upcoming Investor Conferences